Innovative treatments and transformative therapies in brain health are on the horizon thanks to a £35.4 million award to the NIHR Oxford Health Biomedical Research Centre. The award, announced on…
Two drugs, eszopiclone and lemborexant – both not currently licenced for the treatment of insomnia in the UK – were shown to perform better than others, both in the acute…
In a landmark development, psychological therapy has been automated in virtual reality. With the user guided by a virtual coach, there is no need for a real-life therapist, meaning the treatment can reach many more patients.
This blog was written by Emma Osborne, research assistant at the Centre for Research on Eating Disorders at the University of Oxford (CREDO) and Dr Rebecca Murphy, co-director of CREDO and NIHR Clinical Doctoral Research Fellow.
